NL189670B - PROCESS FOR PREPARING A 7- (D-ALFA-ALFA- (P-HYDROXYPHENYL) ACETAMIDO) -3- (HETEROCYCLYLTHIOMETHYL) -3-CEFEM-4-CARBONIC ACID DERIVATIVE AND AN ANIMAL PHARMACEUTICAL PREPARATOR. - Google Patents

PROCESS FOR PREPARING A 7- (D-ALFA-ALFA- (P-HYDROXYPHENYL) ACETAMIDO) -3- (HETEROCYCLYLTHIOMETHYL) -3-CEFEM-4-CARBONIC ACID DERIVATIVE AND AN ANIMAL PHARMACEUTICAL PREPARATOR.

Info

Publication number
NL189670B
NL189670B NLAANVRAGE7611026,A NL7611026A NL189670B NL 189670 B NL189670 B NL 189670B NL 7611026 A NL7611026 A NL 7611026A NL 189670 B NL189670 B NL 189670B
Authority
NL
Netherlands
Prior art keywords
alfa
heterocyclylthiomethyl
preparator
cefem
acetamido
Prior art date
Application number
NLAANVRAGE7611026,A
Other languages
Dutch (nl)
Other versions
NL189670C (en
NL7611026A (en
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/653,999 external-priority patent/US4026888A/en
Priority claimed from US05/654,314 external-priority patent/US4061862A/en
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NL7611026A publication Critical patent/NL7611026A/en
Publication of NL189670B publication Critical patent/NL189670B/en
Application granted granted Critical
Publication of NL189670C publication Critical patent/NL189670C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/58Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with a nitrogen atom, which is a member of a hetero ring, attached in position 7

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7611026,A 1975-10-06 1976-10-06 PROCESS FOR PREPARING A 7- (D-ALFA-ALFA- (P-HYDROXYPHENYL) ACETAMIDO) -3- (HETEROCYCLYLTHIOMETHYL) -3-CEFEM-4-CARBONIC ACID DERIVATIVE AND AN ANIMAL PHARMACEUTICAL PREPARATOR. NL189670C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62000575A 1975-10-06 1975-10-06
US62230675A 1975-10-10 1975-10-10
US64031775A 1975-12-12 1975-12-12
US05/653,999 US4026888A (en) 1975-10-10 1976-01-30 Certain derivatives of particular 3-thiolated cephalosporins
US05/654,314 US4061862A (en) 1975-10-06 1976-02-02 Derivatives of 7-(cyclized)phenylglycyl-3-triazolo-thio methyl cephalosporin

Publications (3)

Publication Number Publication Date
NL7611026A NL7611026A (en) 1977-04-12
NL189670B true NL189670B (en) 1993-01-18
NL189670C NL189670C (en) 1993-06-16

Family

ID=27542000

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7611026,A NL189670C (en) 1975-10-06 1976-10-06 PROCESS FOR PREPARING A 7- (D-ALFA-ALFA- (P-HYDROXYPHENYL) ACETAMIDO) -3- (HETEROCYCLYLTHIOMETHYL) -3-CEFEM-4-CARBONIC ACID DERIVATIVE AND AN ANIMAL PHARMACEUTICAL PREPARATOR.

Country Status (17)

Country Link
JP (1) JPS6052718B2 (en)
AU (1) AU511344B2 (en)
BE (1) BE846890A (en)
CA (1) CA1113927A (en)
CH (1) CH629500A5 (en)
CY (1) CY1121A (en)
DE (1) DE2645144C2 (en)
DK (2) DK158673C (en)
FR (1) FR2326926A1 (en)
GB (1) GB1521419A (en)
HK (1) HK41281A (en)
IE (1) IE43666B1 (en)
KE (1) KE3154A (en)
LU (1) LU75935A1 (en)
NL (1) NL189670C (en)
SE (1) SE434952B (en)
YU (1) YU40287B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54112892A (en) * 1978-02-23 1979-09-04 Shionogi & Co Ltd Substituted imidazolidinyl-3-chloro-3-cephem-4-carboxylic acid
JPS54115354A (en) * 1978-02-27 1979-09-07 Chugai Pharmaceut Co Ltd Biphenylylglycine derivative
WO2019168164A1 (en) * 2018-03-02 2019-09-06 国立大学法人大阪大学 Molecule for protein and/or peptide design

Also Published As

Publication number Publication date
DK158673B (en) 1990-07-02
DK158673C (en) 1991-01-14
FR2326926A1 (en) 1977-05-06
DK200488A (en) 1988-04-12
IE43666L (en) 1977-04-06
FR2326926B1 (en) 1980-07-11
LU75935A1 (en) 1977-05-25
SE434952B (en) 1984-08-27
IE43666B1 (en) 1981-04-22
SE7610989L (en) 1977-04-07
KE3154A (en) 1981-09-18
DK200488D0 (en) 1988-04-12
YU243176A (en) 1982-06-30
YU40287B (en) 1985-12-31
CY1121A (en) 1981-12-04
JPS6052718B2 (en) 1985-11-20
CA1113927A (en) 1981-12-08
JPS5246094A (en) 1977-04-12
DK164225B (en) 1992-05-25
DK446576A (en) 1977-04-07
NL189670C (en) 1993-06-16
AU1824576A (en) 1978-04-06
NL7611026A (en) 1977-04-12
DE2645144A1 (en) 1977-04-14
GB1521419A (en) 1978-08-16
CH629500A5 (en) 1982-04-30
DE2645144C2 (en) 1986-11-27
HK41281A (en) 1981-08-28
DK164225C (en) 1992-10-19
BE846890A (en) 1977-04-01
AU511344B2 (en) 1980-08-14

Similar Documents

Publication Publication Date Title
NL189354C (en) PROCESS FOR PREPARING AN ANTIMICROBIAL PREPARATION, AND PROCESS FOR PREPARING A DERIVATIVE OF A 7- (2- (2-IMINO-4-THIAZOLIN-4-YL) ACETAMIDO) -3-CEPHEM-4-CARBONIC ACID.
NL7515199A (en) PROCESS FOR PREPARING AMINO ACID PREPARATIONS.
NL178862C (en) METHOD FOR PREPARING AN AEROGLICALLY-STRUCTURED FACTIC ACID
NL7705574A (en) METHOD FOR PREPARING PHENOXY-PHENOXY-PROPIONIC ACID DERIVATIVES.
NL7606809A (en) METHOD FOR PREPARING TEREPHALIC ACID.
NL176863C (en) PROCESS FOR PREPARING A FINALLY DIVIDED FACTIC ACID.
NL182954C (en) PROCESS FOR PREPARING ALFA-AMINO ACID AMIDE
NL185924B (en) PROCESS FOR THE PREPARATION OF A 7- (D-ALFA-AMINO-ALFA- (P-HYDROXYPHENYL) ACETAMIDO) -3- (1,2,3-TRIAZOLO-5-YLTHIOMETHYL) -3-CEPHEM-4-CARBONIC ACID COMPOUND, AND OF AN ANTIBACTERIAL ACTIVE PHARMACEUTICAL PREPARATION.
NL190524B (en) PROCESS FOR PREPARING PENICILLIN ESTERS.
NL161454C (en) PROCESS FOR PREPARING 6-D-(-)-ŸALFA-AMINO--ALFA-(P-HYDROXYPHENYL)ACETAMIDOŸPENICILLAN ACID.
NL186695C (en) PROCESS FOR PREPARING NICOTIC ACID AMIDE
NL170623C (en) PROCESS FOR PREPARING CIS-2-PHENYL-2-HYDROXY-R-1-CYCLOHEXANE CARBONIC ACID.
NL168214C (en) PROCESS FOR PREPARING A BETA-DIHALOGENETHENYLCYCLOPROPANIC CARBONIC ACID DERIVATIVE.
NL170148C (en) PROCESS FOR PREPARING A 7- (SUBSTITUTED AMINO) DESACETOXYCEPHALOSPORANIC ACID DERIVATIVE.
NL7610058A (en) METHOD FOR THE PREPARATION OF ANIMAL FEED PREPARATIONS.
NL189670C (en) PROCESS FOR PREPARING A 7- (D-ALFA-ALFA- (P-HYDROXYPHENYL) ACETAMIDO) -3- (HETEROCYCLYLTHIOMETHYL) -3-CEFEM-4-CARBONIC ACID DERIVATIVE AND AN ANIMAL PHARMACEUTICAL PREPARATOR.
NL7612320A (en) PROCESS FOR PREPARING THIAPROSTAN ACID DERIVATIVES.
NL163789C (en) PROCESS FOR PREPARING A 7BETA- (4-CARBOXY-BUTANAAMIDO) CEPHALOSPORANIC ACID DERIVATIVE.
NL186525C (en) PROCESS FOR PREPARING A 7-AMINO-3 (optionally SUBSTITUTED) METHYL-3-CEFEM-4-CARBONIC ACID DERIVATIVE.
NL173644C (en) PROCESS FOR PREPARING ALFA-ALKYLTHIOACETIC ACID DERIVATIVES.
NL170416C (en) PROCESS FOR PREPARING A DERIVATIVE OF 7-AMINOCEPHALOSPORANIC ACID OR 7-AMINODESACETOXYCEPHALOSPORANIC ACID.
NL167595C (en) METHOD FOR PREPARING AN IODOPHORUS SOLUTION
NL7505104A (en) IMPROVEMENT OF A METHOD FOR PROCESSING MELASSE SOLUTIONS.
NL7605889A (en) PROCESS FOR PREPARING M-BENZOYLHYDRATROPIC ACID.
NL187909C (en) PROCESS FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTI-ARTHYMIC EFFECT CONTAINING A 1-AMINOETHOXY-3-ARYLOXY-2-HYDROXYPROPANE DERIVATIVE AND ITS ACID THEREFORE THEREFOR AND THEREFOR

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

V1 Lapsed because of non-payment of the annual fee